GSK:LON
GSK plc
GBX 1,761.50
arrow_upward
+0.66%(+11.50) Siku 1
12 Okt, 14:30:30 GMT +1 · GBX
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya GSK...
Fungua
GBX 1,755.00
Juu
GBX 1,766.00
Chini
GBX 1,751.00
Mtaji wa soko
71.26B
Wastani wa kiasi cha mauzo
5.90M
Kiasi cha mauzo ya hisa
elfu 834.43
Gawio
3.86%
Mgawo wa faida wa kila robo mwaka
GBX 17.00
Tarehe ya kutojumuisha gawio
13 Ago 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
14.93
Juu kwa wiki 52
GBX 2,282.00
Chini kwa wiki 52
GBX 1,592.00
EPS
GBX 1.18
Hisa za wawekezaji
4.32B
Idadi ya wafanyakazi
elfu 67
Fungua
GBX 1,755.00
Juu
GBX 1,766.00
Chini
GBX 1,751.00
Mtaji wa soko
71.26B
Wastani wa kiasi cha mauzo
5.90M
Kiasi cha mauzo ya hisa
elfu 834.43
Gawio
3.86%
Mgawo wa faida wa kila robo mwaka
GBX 17.00
Tarehe ya kutojumuisha gawio
13 Ago 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
14.93
Juu kwa wiki 52
GBX 2,282.00
Chini kwa wiki 52
GBX 1,592.00
EPS
GBX 1.18
Hisa za wawekezaji
4.32B
Idadi ya wafanyakazi
elfu 67
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
ad-hoc-news.de
·
saa 1 iliyopita
GSK stock costs EUR 20.89 with USD 93.2 billion market value
BioSpace
·
saa 2 zilizopita
GSK pledges $800M to add biologics production capabilities in Pennsylvania
Kalkine Media
·
saa 3 zilizopita
Is GSK (LSE:GSK) Shares' Dip After The Nuvalent Deal A Pipeline Story In Focus?
The Pharma Letter
·
saa 3 zilizopita
Over $800 million investment from GSK to expand operations in Pennsylvania
Wasifu
GSK plc is a British multinational pharmaceutical and biotechnology company. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm. It is headquartered in London, England.
GSK is the tenth-largest pharmaceutical company in the world by earnings, $9.32 billion in 2025 with $42.4 billion in revenues in the same period. As of February 2026 it is the 175th most valuable company in the world and the 12th most valuable pharmaceutical company with a market capitalisation of $122.6 billion. It was also ranked 388th on the 2025 Fortune Global 500.
The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index, the eighth largest on the London Stock Exchange behind British pharmaceutical rival AstraZeneca, which occupies the No 1 spot in London at a value of $325 billion, 2.7x more than GSK.
The company developed the first malaria vaccine, RTS, S, which it said in 2014, it would make available for five per cent above cost. Wikipedia
Kuhusu GSK plc
Afisa Mkuu Mtendaji (CEO)Emma Walmsley | Emma Walmsley
Wafanyakazielfu 66.8
Lilianzishwa27 Des 2000
Makao makuu-
Sekta-
Tovutigsk.com